Related Experiment Video

Updated: Jul 16, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

[Radiotherapy for SMARCA4-deficient Pulmonary Neoplasms: 
Efficacy and Related Parameter Analysis].

Yu Gu1,2, Ruxi Gao1,2, Xingwen Fan1,2

  • 1Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.

Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|July 15, 2026
PubMed
Summary

Radiotherapy significantly improves survival for SMARCA4-deficient lung tumors, especially when combined with immunotherapy. Radiotherapy parameters did not impact outcomes, suggesting simpler regimens may be effective for these aggressive cancers.

Keywords:
ImmunotherapyLung neoplasmsRadiotherapySMARCA4 deficiencyUndifferentiated tumor

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...